Study Stopped
Study never approved by the IRB. Was not initiated
Study Comparing Intubation Via Video Laryngeal Mask Airways (VLMAs) Versus Video Laryngoscopy
Pilot Study Comparing Intubation Via Video Laryngeal Mask Airways (VLMAs) Versus Video Laryngoscopy: Efficacy and Patient Outcomes in General Anesthesia Procedures
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The goal of this clinical trial is to compare the overall performance and patient outcomes of two video-assisted laryngeal mask airways (VLMAs) devices called Safe and Comfortable (SaCo) VLM and SafeLM® (Safe VLM) versus video laryngoscopy for airway management in adult patients, without an anticipated difficult airway, that are undergoing elective general anesthesia procedures. The main question it aims to answer is: Can both VLMAs improve patient-centered outcomes in the perioperative and postoperative periods in comparison to endotracheal tube (ETT) intubation? Thirty participants will undergo randomized VLMA with either the Safe VLM (15 participants) or the SaCo VLM (15 participants). And 15 participants will be intubated with ETT using video laryngoscopy, as the control group. Researchers will evaluate the efficacy of these two video-assisted devices in adult patients without an anticipated difficult airway in elective general anesthesia procedures. Other patient outcomes and exploratory endpoints will be recorded as well.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 29, 2024
CompletedFirst Posted
Study publicly available on registry
May 2, 2024
CompletedStudy Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2024
CompletedAugust 9, 2024
August 1, 2024
3 months
April 29, 2024
August 7, 2024
Conditions
Outcome Measures
Primary Outcomes (6)
Successful first-attempt placement rate of VLMA
The first-attempt success rate of VLMA device placement will be determined. Insertion will be considered successful if the VLMA is placed without any resistance and is confirmed to be optimally positioned based on the laryngeal mask visual screen, end-tidal carbon dioxide (CO2) after placement and ventilatory parameters. This will be reported as a dichotomous variable (successful vs unsuccessful).
Intraoperative period, from the beginning of the general anesthesia induction to VLMA placement, up to 30 seconds
Successful first-attempt placement rate of endotracheal intubation via video laryngoscopy
Insertion will be considered successful if the endotracheal tube slides through the VLMA without any resistance and is confirmed to be optimally positioned based on observation via the laryngeal mask visual monitor screen and capnography. This will be reported as a dichotomous variable (successful vs unsuccessful).
Intraoperative period, from the beginning of the general anesthesia induction to ETT placement, up to 45 seconds
Number of participants with change in mean blood pressure by 20% from baseline mean blood pressure
Measurement of blood pressure will be taken before and after intubation.
Perioperative period, from the beginning of the general anesthesia induction to the end of evaluation, up to 1 day
Number of participants with change in heart rate by 20% from baseline heart rate
Measurement of heart rate will be taken before and after intubation.
Perioperative period, from the beginning of the general anesthesia induction to the end of evaluation, up to 1 day
Number of participants change in oxygen saturation by 20% from baseline
Measurement of oxygen saturation will be taken before and after intubation.
Perioperative period, from the beginning of the general anesthesia induction to the end of evaluation, up to 1 day
Incidence of pharyngalgia, bleeding, hoarseness, and dysphagia events
Incidence of pharyngalgia, bleeding, hoarseness, and dysphagia events will be summarized as observed as reported by patients
Postoperative period at 1 hour and 24 hours after procedure
Secondary Outcomes (2)
Incidence of postoperative nausea and vomiting (PONV)
Postoperative period, up to one day following procedure
Number of participants with postoperative hypertension by >30% of baseline, requiring treatment
Postoperative period, up to 1 hour
Study Arms (3)
Safe VLM
EXPERIMENTALThe device will be placed after patient is anesthetized. Following placement, the glottis will be observed and endotracheal tube will be placed.
Video laryngoscopy
ACTIVE COMPARATORFollowing anesthetic induction, endotracheal intubation will be performed with a video laryngoscope.
SaCo VLM
EXPERIMENTALThe device will be placed after patient is anesthetized. Following placement, the glottis will be observed and endotracheal tube will be placed.
Interventions
Once the device is placed, following assessment, endotracheal intubation will be performed via the device.
Endotracheal intubation (size 7.0 mm) using video laryngoscope
Once the device is placed, following assessment, endotracheal intubation will be performed via the device.
Eligibility Criteria
You may qualify if:
- Any sex
- Age ≥ 18 yrs
- BMI ≥ 40 kg/m2
- American Society of Anesthesiologists (ASA) class I-III
- With intention to undergo endotracheal intubation
- Understanding the purpose of the study and signing the informed consent
You may not qualify if:
- ASA IV
- History of upper respiratory infection within 2 weeks
- Presence of risk factors for gastric reflux or aspiration
- Symptomatic bronchial asthma
- Restricted mouth opening (﹤2 cm)
- Upper airway tumors, abscesses, foreign bodies or airway stenosis
- Requiring one-lung ventilation for thoracic surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Montefiore Medical Center
The Bronx, New York, 10467, United States
Related Publications (13)
Gomez-Rios MA, Lopez T, Sastre JA, Gaszynski T, Van Zundert AAJ. Video laryngeal masks in airway management. Expert Rev Med Devices. 2022 Nov;19(11):847-858. doi: 10.1080/17434440.2022.2142558. Epub 2022 Nov 8.
PMID: 36308748RESULTGordon J, Cooper RM, Parotto M. Supraglottic airway devices: indications, contraindications and management. Minerva Anestesiol. 2018 Mar;84(3):389-397. doi: 10.23736/S0375-9393.17.12112-7. Epub 2017 Oct 12.
PMID: 29027772RESULTHussain D, Kundal R, Kumar A, Sabharwal N. An Analysis of the Comparative Efficacy Between a Third-Generation and a Second-Generation Supraglottic Airway Device in Patients Undergoing Laparoscopic Cholecystectomy. Cureus. 2022 Feb 25;14(2):e22592. doi: 10.7759/cureus.22592. eCollection 2022 Feb.
PMID: 35355545RESULTLai CJ, Yeh YC, Tu YK, Cheng YJ, Liu CM, Fan SZ. Comparison of the efficacy of supraglottic airway devices in low-risk adult patients: a network meta-analysis and systematic review. Sci Rep. 2021 Jul 23;11(1):15074. doi: 10.1038/s41598-021-94114-7.
PMID: 34301986RESULTSun Y, Huang L, Xu L, Zhang M, Guo Y, Wang Y. The Application of a SaCoVLMTM Visual Intubation Laryngeal Mask for the Management of Difficult Airways in Morbidly Obese Patients: Case Report. Front Med (Lausanne). 2021 Nov 18;8:763103. doi: 10.3389/fmed.2021.763103. eCollection 2021.
PMID: 34869469RESULTTimmermann A, Bergner UA, Russo SG. Laryngeal mask airway indications: new frontiers for second-generation supraglottic airways. Curr Opin Anaesthesiol. 2015 Dec;28(6):717-26. doi: 10.1097/ACO.0000000000000262.
PMID: 26539790RESULTVan Zundert AAJ, Gatt SP, Van Zundert TCRV, Kumar CM, Pandit JJ. Features of new vision-incorporated third-generation video laryngeal mask airways. J Clin Monit Comput. 2022 Aug;36(4):921-928. doi: 10.1007/s10877-021-00780-3. Epub 2021 Dec 17.
PMID: 34919170RESULTVan Zundert AAJ, Kumar CM, Van Zundert TCRV, Gatt SP, Pandit JJ. The case for a 3rd generation supraglottic airway device facilitating direct vision placement. J Clin Monit Comput. 2021 Apr;35(2):217-224. doi: 10.1007/s10877-020-00537-4. Epub 2020 Jun 15.
PMID: 32537697RESULTvan Zundert AAJ, Wyssusek KH, Pelecanos A, Roets M, Kumar CM. A prospective randomized comparison of airway seal using the novel vision-guided insertion of LMA-Supreme(R) and LMA-Protector(R). J Clin Monit Comput. 2020 Apr;34(2):285-294. doi: 10.1007/s10877-019-00301-3. Epub 2019 Apr 5.
PMID: 30953222RESULTVan Zundert AA, Kumar CM, Van Zundert TC. Malpositioning of supraglottic airway devices: preventive and corrective strategies. Br J Anaesth. 2016 May;116(5):579-82. doi: 10.1093/bja/aew104. No abstract available.
PMID: 27106958RESULTYan CL, Zhang YQ, Chen Y, Qv ZY, Zuo MZ. Comparison of SaCoVLM video laryngeal mask-guided intubation and i-gel combined with flexible bronchoscopy-guided intubation in airway management during general anesthesia: a non-inferiority study. BMC Anesthesiol. 2022 Sep 22;22(1):302. doi: 10.1186/s12871-022-01843-x.
PMID: 36138363RESULTYan CL, Chen Y, Sun P, Qv ZY, Zuo MZ. Preliminary evaluation of SaCoVLM video laryngeal mask airway in airway management for general anesthesia. BMC Anesthesiol. 2022 Jan 3;22(1):3. doi: 10.1186/s12871-021-01541-0.
PMID: 34979936RESULTZhi J, Deng XM, Zhang YM, Wei LX, Wang QY, Yang D. Preliminary evaluation of SaCoVLM video laryngeal mask-guided intubation in airway management for anesthetized children. BMC Anesthesiol. 2023 Feb 8;23(1):49. doi: 10.1186/s12871-023-01996-3.
PMID: 36755214RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Irene Osborn, MD
Montefiore Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participant will have agreed to the study and randomized device or technique will be used.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 29, 2024
First Posted
May 2, 2024
Study Start
July 1, 2024
Primary Completion
October 1, 2024
Study Completion
October 1, 2024
Last Updated
August 9, 2024
Record last verified: 2024-08